103 related articles for article (PubMed ID: 27619777)
1. Long-term health care costs for patients with prostate cancer: a population-wide longitudinal study in New South Wales, Australia.
Cronin P; Kirkbride B; Bang A; Parkinson B; Smith D; Haywood P
Asia Pac J Clin Oncol; 2017 Jun; 13(3):160-171. PubMed ID: 27619777
[TBL] [Abstract][Full Text] [Related]
2. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
[TBL] [Abstract][Full Text] [Related]
3. Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study.
Yu XQ; Luo Q; Smith DP; Clements MS; Patel MI; O'Connell DL
PLoS One; 2017; 12(2):e0171013. PubMed ID: 28178275
[TBL] [Abstract][Full Text] [Related]
4. Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis.
Gordon LG; Tuffaha HW; James R; Keller AT; Lowe A; Scuffham PA; Gardiner RA
Urol Oncol; 2018 Mar; 36(3):91.e7-91.e15. PubMed ID: 29169847
[TBL] [Abstract][Full Text] [Related]
5. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
[TBL] [Abstract][Full Text] [Related]
6. Cumulative cost pattern comparison of prostate cancer treatments.
Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
[TBL] [Abstract][Full Text] [Related]
7. Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study.
Goldsbury DE; Smith DP; Armstrong BK; O'Connell DL
BMC Health Serv Res; 2011 Oct; 11():253. PubMed ID: 21978077
[TBL] [Abstract][Full Text] [Related]
8. Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data.
Stokes ME; Black L; Benedict A; Roehrborn CG; Albertsen P
Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):278-84. PubMed ID: 20212521
[TBL] [Abstract][Full Text] [Related]
9. Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis.
Sanyal C; Aprikian AG; Cury FL; Chevalier S; Dragomir A
Cancer; 2016 Apr; 122(7):1085-96. PubMed ID: 26828716
[TBL] [Abstract][Full Text] [Related]
10. Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer.
Burkhardt JH; Litwin MS; Rose CM; Correa RJ; Sunshine JH; Hogan C; Hayman JA
J Clin Oncol; 2002 Jun; 20(12):2869-75. PubMed ID: 12065564
[TBL] [Abstract][Full Text] [Related]
11. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
Brandeis J; Pashos CL; Henning JM; Litwin MS
Cancer; 2000 Oct; 89(8):1792-9. PubMed ID: 11042575
[TBL] [Abstract][Full Text] [Related]
12. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
13. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
14. [Treatment costs of localized prostate cancer in Germany : Economic results from the HAROW observational study].
Reinhold T; Dornquast C; Börgermann C; Weißbach L
Urologe A; 2016 Dec; 55(12):1573-1585. PubMed ID: 27822603
[TBL] [Abstract][Full Text] [Related]
15. [Cost comparison of three treatments for localized prostate cancer in Spain: radical prostatectomy, prostate brachytherapy and external 3D conformal radiotherapy].
Becerra Bachino V; Cots F; Guedea F; Pera J; Boladeras A; Aguiló F; Suárez JF; Gallo P; Murgui L; Pont A; Cunillera O; Pardo Y; Ferrer M;
Gac Sanit; 2011; 25(1):35-43. PubMed ID: 21316126
[TBL] [Abstract][Full Text] [Related]
16. Economic analysis of active surveillance for localized prostate cancer.
Kim S; Dall'Era MA; Evans CP
Curr Opin Urol; 2012 May; 22(3):247-53. PubMed ID: 22388666
[TBL] [Abstract][Full Text] [Related]
17. Health Care Costs Attributable to Prostate Cancer in British Columbia, Canada: A Population-Based Cohort Study.
Zhang W; Guh DP; Mohammadi T; Pataky RE; Tam ACT; Lynd LD; Conklin AI
Curr Oncol; 2023 Mar; 30(3):3176-3188. PubMed ID: 36975453
[TBL] [Abstract][Full Text] [Related]
18. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
Poon I; Pintilie M; Potvin M; McGowan T
Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
[TBL] [Abstract][Full Text] [Related]
19. Costs of radical prostatectomy for prostate cancer: a systematic review.
Bolenz C; Freedland SJ; Hollenbeck BK; Lotan Y; Lowrance WT; Nelson JB; Hu JC
Eur Urol; 2014 Feb; 65(2):316-24. PubMed ID: 22981673
[TBL] [Abstract][Full Text] [Related]
20. What does it cost Medicare to diagnose and treat men with localized prostate cancer in the first year?
Mervin MC; Lowe A; Gardiner RA; Smith DP; Aitken J; Chambers SK; Gordon LG
Asia Pac J Clin Oncol; 2017 Jun; 13(3):152-159. PubMed ID: 28303657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
